Technical420 Site Search

Although the biotech sector will be one of the greatest beneficiaries of the legal cannabis movement, the sector has recently been under pressure and this weakness has created significant opportunities for investors.The iShares Nasdaq Biotechnology ETF (IBB), which is often used to measure the strength of the biotech sector has…

There have been a number of questions raised about Zynerba Pharmaceuticals’ upcoming inital public offering (IPO) to which I would like to address. Tomorrow, ZYNE will commence trading on the NASDAQ exchange and they will issue 3,000,000 shares which will be priced tonight.Zynerba is looking to raise $36.3 million at a…

Investors, it is time to set aside some cash! On Wednesday, Zynerba Pharmaceuticals, Inc. (ZYNE) will have its initial public offering (IPO) on the NASDAQ exchange. Zynerba will issue 3,000,000 shares and they will be offered in the $13.00-$15.00 range. The total offering amount is $51.75 million (total expenses are…

Currently, 40 states have passed laws that allow for the use of some form of medical marijuana. Even though marijuana clearly has medical benefits, it remains a Schedule I substance alongside heroin, LSD, ecstasy, and bath salts under the Controlled Substances Act (CSA). According to the United States Drug Enforcement…

Yesterday, Zynerba Pharmaceuticals announced the terms of its upcoming initial public offering (IPO). The Pennsylvania-based company plans to raise $42 million by offering 3 million shares in the $13-$15 range. At the midpoint of the proposed range, it would have a fully diluted market value of $128 million. Shares are…

Investors and financial institutions have shown great interest for publicly traded cannabis companies, but many are afraid to invest in them because most trade on the over-the-counter (OTC) exchange. The OTC exchange, also known as the Pink Sheets, is comprised of startups, defunct public shell companies, scams, and a few…

Investors and financial institutions have been patiently waiting for a cannabis-related company to commence trading on a national exchange like the Nasdaq or New York Stock Exchange. Currently, there are only two cannabis related biotech companies that trade on the Nasdaq. These are GW Pharmaceuticals (GWPH) and INSYS Therapeutics, Inc.…